Ross Caputo, Ph.D. becomes Eagle President and Chief Executive Officer.
Compounding Pharmacy Compliance, 08/17 – 08/18

Eagle went to Boston!

Did you attend the presentation by Dr. Ross A. Caputo, Ph.D. at the Compounding Pharmacy Compliance Congress, where he discussed achieving Category 3 Beyond-Use Dates?

If you have questions about any of the Category 3 BUD requirements, make sure to visit our Eagle Team representatives: Lisa JohnsonJacqueline Esqueda, PharmD, BCSCP, RPh, and Steve Kummer.
They are here to help you!

Event Information | Presentation Clip